Multicenter stress cardiac MRI measuring heart muscle blood flow
Official title: The Multicenter Stress Cardiac Magnetic Resonance Quantitative Perfusion Imaging in the United States (SPINS2) Study
Run by Brigham and Women's Hospital · NCT06854458 · Data updated 2026-11-12
This will test whether detailed stress cardiac MRI blood-flow measurements help identify heart-related causes of chest pain or shortness of breath in adults 35–85 with suspected coronary artery disease.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 35 Years to 85 Years |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Brigham and Women's Hospital Academic / other |
| Locations | 13 sites (San Francisco, California and 12 other locations) |
| Status | Recruiting |
| Started | June 27, 2025 |
| Main results expected | January 2029 |
| Study ends | March 2029 |
| Registry record updated | September 1, 2026 |
| Trial ID | NCT06854458 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 35–85 who have chest pain or an anginal equivalent or an abnormal ECG with suspicion of coronary disease and intermediate or high pretest risk factors are the intended participants.
✕Probably not a fit
Patients without suspected ischemia, those with recent acute myocardial infarction within 30 days, standard contraindications to MRI or gadolinium, or very low pretest risk are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter study will enroll adults with chest pain or abnormal ECGs and intermediate-to-high risk features and perform standardized quantitative stress cardiac MRI across participating U.S. centers. Each participant will undergo vasodilator stress (regadenoson or adenosine) with gadolinium-based contrast (Gadavist 0.05 mmol/kg for stress and 0.05 mmol/kg for rest) to generate quantitative myocardial blood flow and flow reserve measurements alongside routine qualitative perfusion imaging. Investigators will compare quantitative perfusion indices to qualitative imaging and clinical risk factors to see whether abnormal blood-flow measurements predict higher rates of adverse cardiac events and better characterize multivessel disease. Results will be used to determine whether quantitative perfusion should influence decisions about invasive testing or early targeted medical therapy.
Why it matters
Potential benefit: If successful, this approach could help doctors more accurately detect reduced blood flow to the heart and better target invasive testing or preventive treatments to higher-risk patients.
How similar studies have gone: Prior smaller studies have suggested quantitative myocardial perfusion MRI can improve diagnostic accuracy, but this larger multicenter effort aims to validate those findings in a U.S. cohort.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. male or female at age 35-85 years, 2. presence of either of the following sign/symptom that led to a referral to stress cardiac magnetic resonance imaging: 1. chest pain or anginal equivalent, or 2. abnormal electrocardiogram with a suspicion of coronary artery disease 3. Intermediate or high risk of significant coronary disease based on at least 1 of the following conditions: a) patient age \> 45 for male, 50 for female b) Diabetes, hypertension, or hypercholesterolemia: by either history or medical treatment c) family history of premature coronary disease: first degree relative at age \<= 55 male and \<=65 female d) history of smoking of \> 10 packed-years e) post-menopausal state \>5 years f) any chronic inflammatory conditions d) Body mass index \> 30 e) Any medical documentation of coronary or peripheral artery disease Exclusion Criteria: 1. Acute myocardial infarction within the past 30 days prior to cardiac magnetic resonance imaging 2. Confirmed diagnosis of any significant non-coronary cardiac conditions below: 1. any severe-grade valvular heart disease, 2. left ventricular ejection fraction \<40% from any known non-coronary causes, 3. infiltrative cardiomyopathy, 4. hypertrophic cardiomyopathy, 5. pericardial disease with significant constriction, or 3. active pregnancy, 4. any competing conditions leading to an expected survival of \< 2 years 5. contraindication to vasodilator (regadenoson or adenosine) 6. metallic device or object that poses an magnetic resonance imaging safety hazard 7. metallic device with a high likelihood of non-diagnostic cardiac magnetic resonance images
Where it's running
-
University of California San Francisco
San Francisco, California, United States Recruiting -
UofL Health - Heart Hospital
Louisville, Kentucky, United States Recruiting -
Brigham and Women's Hospital
Boston, Massachusetts, United States Recruiting -
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States Recruiting -
St. Francis Hospital and Heart Center
Roslyn, New York, United States Recruiting -
Atrium Health - Sanger Heart & Vascular Institute
Charlotte, North Carolina, United States Recruiting
Show 7 more locations
-
Cleveland Clinic
Cleveland, Ohio, United States Recruiting -
The Ohio State University
Columbus, Ohio, United States Recruiting -
Vanderbilt University Medical Center
Nashville, Tennessee, United States Recruiting -
Houston Methodist Hospital
Houston, Texas, United States Recruiting -
University of Utah
Salt Lake City, Utah, United States Recruiting -
University of Virginia
Charlottesville, Virginia, United States Recruiting -
Virginia Commonwealth University
Richmond, Virginia, United States Recruiting
Study contacts
- Study coordinator: Raymond Y Kwong, MD, MPH
- Email: rykwong@bwh.harvard.edu
- Phone: 857-307-1960
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Multimodal regional nerve blocks to improve recovery after off-pump CABG
This study tests whether using multiple regional nerve blocks can reduce pain and help patients recover after off-pump coronary artery bypass surgery.
-
Revascularization of Calcified Coronary Arteries
This study tests whether measuring blood flow and pressure before and after ballooning or stenting of calcified coronary arteries can help predict how well the procedure will work for adults with heart disease.
-
4D MRI parameters linked to cardiovascular and cancer disease outcomes
This study tests whether 4D MRI measurements can predict how cardiovascular diseases and cancer will progress in adults undergoing routine cardiac MRI at a single Korean hospital.
-
Multimodal Cardiac MRI to See How the Heart Is Working
This study tests a comprehensive MRI approach to characterize heart structure and tissue in adults with suspected or confirmed cardiovascular disease.
-
Personalized online psychological program for people with ischemic heart disease and anxiety or depression
This project will test a personalized, therapist-supported online program to see if it helps adults with ischemic heart disease who have anxiety or depression.
-
FAPI PET/CT imaging in arrhythmogenic right ventricular cardiomyopathy
This study will test whether a PET/CT scan using a 68Ga-DOTA-SA-FAPI tracer can detect active scarring in adults with ARVC and provide information beyond standard heart imaging.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.